US20130011451A1 - Footbed with non-denatured collagen - Google Patents
Footbed with non-denatured collagen Download PDFInfo
- Publication number
- US20130011451A1 US20130011451A1 US13/176,841 US201113176841A US2013011451A1 US 20130011451 A1 US20130011451 A1 US 20130011451A1 US 201113176841 A US201113176841 A US 201113176841A US 2013011451 A1 US2013011451 A1 US 2013011451A1
- Authority
- US
- United States
- Prior art keywords
- denatured collagen
- agents
- composite material
- footbed
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001436 collagen Polymers 0.000 title claims abstract description 90
- 108010035532 Collagen Proteins 0.000 title claims abstract description 87
- 102000008186 Collagen Human genes 0.000 title claims abstract description 87
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 239000000654 additive Substances 0.000 claims abstract description 28
- 230000000996 additive effect Effects 0.000 claims abstract description 26
- 239000000835 fiber Substances 0.000 claims abstract description 18
- 239000002131 composite material Substances 0.000 claims description 27
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 239000006260 foam Substances 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000004925 denaturation Methods 0.000 claims description 10
- 230000036425 denaturation Effects 0.000 claims description 10
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 239000003429 antifungal agent Substances 0.000 claims description 7
- 229940121375 antifungal agent Drugs 0.000 claims description 7
- 229940030225 antihemorrhagics Drugs 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 7
- 239000000645 desinfectant Substances 0.000 claims description 7
- 230000000249 desinfective effect Effects 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000002874 hemostatic agent Substances 0.000 claims description 7
- 239000000416 hydrocolloid Substances 0.000 claims description 7
- 102000039446 nucleic acids Human genes 0.000 claims description 7
- 108020004707 nucleic acids Proteins 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 239000006174 pH buffer Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000005060 rubber Substances 0.000 claims description 7
- 239000000344 soap Substances 0.000 claims description 7
- 239000003206 sterilizing agent Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 230000010399 physical interaction Effects 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 3
- -1 acyl azides Chemical class 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 229920000247 superabsorbent polymer Polymers 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 2
- 238000004513 sizing Methods 0.000 claims description 2
- 230000035939 shock Effects 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 5
- 108010077465 Tropocollagen Proteins 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 102000000503 Collagen Type II Human genes 0.000 description 2
- 108010041390 Collagen Type II Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013538 functional additive Substances 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108060002894 fibrillar collagen Proteins 0.000 description 1
- 102000013373 fibrillar collagen Human genes 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000000032 mammalian fat body Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000286 proflavine Drugs 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/02—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles for articles of definite length, i.e. discrete articles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/0085—Use of fibrous compounding ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2075/00—Use of PU, i.e. polyureas or polyurethanes or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/04—Condition, form or state of moulded material or of the material to be shaped cellular or porous
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0092—Other properties hydrophilic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2489/00—Characterised by the use of proteins; Derivatives thereof
Definitions
- the invention relates to a composition comprising non-denatured collagen fibers complexed with a hydrophilic urethane foam and a method of making the same.
- the human foot is constructed to act as a natural shock absorber, cushioning the rest of the body from the forces encountered through movements such as walking, running, or jumping.
- shock absorption the most vital structural component of the foot is the corpus adiposum of the heel, or heel pad.
- natural breakdown of the heel pad can lead to a loss of this natural shock absorption, potentially causing pain in either the foot or health problems in other parts of the body like the legs or lower back.
- Modern shoe technology has allowed manufacturers to counteract the loss of this natural shock adsorption by providing shoes with footbeds designed to act as auxiliary shock absorbers.
- these footbeds mimic the properties of the heel pad and help augment the natural shock absorption in the user's feet.
- Some footbeds have been produced with functional additives dispersed throughout the foam, endowing the footbed with functionalities such as moisture and odor absorption or skin care and treatment.
- these wholly synthetic footbeds can only approximate the healthy walking platform naturally provided by the human foot's heel pad.
- fully synthetic footbeds are rarely made out of environmentally friendly materials, or at least made from recycled materials to limit excess waste in an increasingly environmentally conscious world.
- composition fashioned into a footbed for providing improved shock absorbing functionality to footwear. More particularly, what is desired is footbed with improved shock absorbing functionality which is fashioned utilizing environmentally conscious materials that does not sacrifice functionality, durability, or cost effective production and distribution. What is further desired is a composition and a method for providing a composition which harnesses the natural properties of non-denatured collagen fibers to fulfill the above-mentioned desires.
- this is done through a method for providing a footbed with non-denatured collagen comprising the steps of forming an aqueous mixture having at least a predetermined amount of non-denatured collagen and water and metering a predetermined amount of a prepolymer with said aqueous mixture to form a foam layer.
- the method further comprises the step of adding to the aqueous mixture an agent from the group consisting of: a cross-linking agent, a catalyst, and a combination thereof.
- the method further comprises the steps of depositing the aqueous mixture on releasable bottom paper disposed on a movable carrier, covering the upper surface of the aqueous mixture with releasable top paper as the aqueous mixture is moved with the movable carrier, advancing the foam layer in the top and bottom release paper by moving the carrier, sizing the foam layer to the desired thickness, removing the top and bottom releasable paper and simultaneously drying the sized and formed footbed to remove moisture.
- the non-denatured collagen throughout the foam layer.
- the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
- One embodiment of the instant invention is a composite material for use as a footbed which comprises a prepolymer, a non-denatured collagen, and at least one additive.
- the non-denatured collagen is dispersed throughout the composite material.
- the non-denatured collagen is separated from a natural source and comprises non-denatured collagen fibrils, and an inter-fibril bond and an intra-fibril bond for retaining the structural rigidity of the non-denatured collagen are unbroken after separation.
- a concentration of the at least one additive in the reaction composition is approximately 0.5% to approximately 15% by weight.
- the non-denatured collagen has a denaturation temperature above 54 degrees Celsius. In yet another embodiment, the non-denatured collagen has a denaturation temperature above 64 degrees Celsius.
- the non-denatured collagen is comprised of a cross-linked non-denatured collagen fiber in a configuration substantially similar to a naturally occurring collagen fiber.
- composite material is produced by a polymerization reaction composition further comprising a cross-linking agent for stabilizing a chemical and a physical interaction between the polymer and the non-denatured collagen.
- a concentration of the prepolymer in the reaction composition is between approximately 10% and approximately 75% by weight.
- the composite material further includes a superabsorbent polymer.
- the instant invention comprises at least one layer adjacent to the composite material.
- the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
- the at least one layer is disposed as a cover layer.
- one embodiment of the instant invention is a reaction composition for use in producing a composite footbed comprising a urethane prepolymer, a non-denatured collagen fibril, an additive selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof, a cross-linking agent selected from the group consisting of: carbodiimides, acyl azides, glutaraldehyde, and combinations thereof, and a catalyst, wherein the composite footbed further comprises a layer disposed proximate to at least one portion of said footbed, and the layer is a cover layer.
- an additive selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents,
- FIG. 1 depicts a molecular representation of a tropocollagen molecule.
- FIG. 2 a and FIG. 2 b depicts an embodiment of a construct of non-denatured collagen and a polymeric network as envisioned by the instant invention.
- FIG. 3 depicts a method of making a construct of non-denatured collagen and a polymeric network of FIG. 2 a and FIG. 2 b.
- FIG. 4 depicts an embodiment of the method of adding at least one additive from FIG. 3 .
- FIG. 5 depicts an embodiment of the instant invention in which the method described in FIG. 3 is used to provide a footbed and an additional cover layer.
- FIGS. 1-5 In describing the various embodiments of the instant invention, reference will be made herein to FIGS. 1-5 in which like numerals refer to like features of the invention.
- a naturally occurring collagen fiber is stabilized by a plurality of forces, such as inter-fibril bonds and intra-fibril bonds.
- inter-fibril bonds it is the bonding between collagen fibrils in a collagen fiber network that help increase the stability of the whole.
- the bonds can be covalent or non-covalent.
- intra-fibril bonds however in this case it is the interactions within the individual tropocollagen that provide an internal stabilizing force.
- FIG. 1 displays the tropocollagen molecule 10 of naturally occurring collagen fibrils.
- the intra-fibril bonds 1000 between the sub-units of this triple-helical structure provide for highly stable constructs which associate via inter-fibril (not-pictured) bonding with other like tropocollagen to form highly structured and stable networks of collagen fibers.
- the non-denatured collagen of this invention retain these inter and intra-fibril bonds, and therefore retain the stabilizing forces found in their naturally occurring counterparts.
- the non-denatured collagen of this invention maintain the advantageous properties from naturally occurring collagen absent in the denatured collagen of the prior art, namely increased stability at higher temperatures, improved absorption capabilities, and the like.
- the separated non-denatured collagen of this invention retain the advantageous properties of naturally occurring collagen through a separation process which avoids the harsh acid, base, and temperature treatments so common in the prior art methods.
- Prior art methods typically utilize highly basic and highly acidic washes to facilitate separation of the naturally occurring collagen from a source, such as an animal hide. These washes, however, can have a profound effect on the fibrillar collagen structure, severing vital structural bonds and leading to lower denaturation temperatures of the separated collagen network.
- Prior art methods also commonly comprise a drying step, in which the separated collagen sample is subjected to high heat in order remove excess moisture from the sample. However, subjecting the separated collagen to high temperatures may cause at least partial denaturation of the collagen network, once again severing the vital structural bonds and leading to a more denatured collagen sample.
- the separated collagen networks of this invention retain the structure and functionality of naturally occurring collagen networks, and therefore impart this functionality to consumer products better than the prior art collagen complexes.
- the separated non-denatured collagen fibers utilized in this invention closely mimic the behavior and functionality of naturally occurring collagen fibers.
- a common by-product of separated and processed collagen samples from the prior art is a lower denaturation temperature, often times as low as 50 degrees Celsius.
- the non-denatured collagen of the instant invention have denaturation temperatures above 54 degrees Celsius, or in another embodiment greater than 64 degrees Celsius. The non-denatured collagen of the instant invention, therefore, retain more of the advantageous properties of naturally occurring collagen than do their prior art counterparts.
- the polymeric composition of the instant invention draws heavily on the teachings of U.S. Pat. No. 5,763,335, U.S. Pat. No. 5,976,616, U.S. Pat. No. 6,025,287, U.S. Pat. No. 6,566,576, and U.S. Pat. No. 6,706,775, all incorporated herein by reference.
- the prior art foam compositions and methods of making said foam compositions represent proven, powerful technology.
- FIG. 5 shows one embodiment in which non-denatured collagen is complexed with a polymer to provide a footbed for a shoe.
- the non-denatured collagen is shown to be distributed throughout the footbed, though in additional embodiments the non-denatured collagen is localized to certain regions of the footbed, such as only in the heel or only in the heel and the ball of the foot.
- the non-denatured collagen complexes with the polymer network of the footbed by any suitable means, such as chemical (covalent and non-covalent bonding) or physical interactions.
- Non-denatured collagen fibrils are known to have active sites and pendant groups available for reaction.
- the non-denatured collagen is of the Type-II variety, though the invention is not limited to the use of Type-II collagen alone.
- Type-II collagen allows for a certain degree of reversible compressibility, making it ideal for use in the footbed of the instant invention.
- FIG. 3 shows one embodiment of the method of making a footbed with non-denatured collagen.
- a non-denatured collagen sample from, in one embodiment, a natural source such as a bovine hide
- an aqueous mixture is formed 100 having a mixture of said non-denatured collagen and water.
- the amount of water in the aqueous mixture is between approximately 15% and approximately 95% by weight. Less than approximately 15% water by weight will lead to unnecessary difficulties during the component admixing process, while concentrations of approximately 95% by weight will disadvantageously limit the amounts other components are added to the composition.
- metered 110 a predetermined amount of a prepolymer, such as those taught in U.S. Pat. No.
- the predetermined amount of prepolymer is approximately 10% to approximately 75% by weight of the aqueous mixture, which covers the approximate operational range of the present invention. Below approximately 10% by weight prepolymer in the aqueous mixture yields a final composition with compromised durability and stability characteristics, whereas above approximately 75% by weight of the aqueous mixture unduly limits the available space for other components without necessarily imparting any further advantageous functionality to the finished product to compensate. In some embodiments, the range is closer to approximately 20% to approximately 50% by weight of the aqueous mixture, said range striking an advantageous balance between durability, cost-effectiveness, and sufficient space for other components.
- the prepolymer is a urethane and part of a two-part urethane system.
- the non-denatured collagen is dispersed 120 throughout the whole footbed, or be localized to a specific region of the footbed.
- at least one additive is present in the aqueous mixture.
- the complexing of the polymers and the non-denatured collagen is aided by the addition 130 of a cross-linking agent to the aqueous mixture.
- Cross-linking agents increase the total number of interactions between the various components of the footbed, whether they be collagen-collagen, collagen-prepolymer, prepolymer-prepolymer interactions, or the like.
- Cross-linking agents suitable for use in the reaction composition of the instant invention include, but are not limited to, carbodiimides, acyl azides, glutaraldehyde, and the like.
- a catalytic agent is added to the aqueous mixture to promote the polymerization reaction between the non-denatured collagen fibrils and the prepolymer.
- Potentially useful catalysts include, but are not limited to, methylene blue, riboflavin, proflavin, eosin, pyridoxal-5-phosphate, and the like.
- the non-denatured collagen/polymer complex 2 of the instant invention resembles the structure portrayed in FIG. 2 a and FIG. 2 b .
- the non-denatured collagen 210 is stabilized internally through the aforementioned inter- and intra-fibril bonds, and is then complexed with the polymeric network 200 through chemical or physical interactions, and then stabilized by crosslinking.
- the aqueous mixture is deposited 140 on releasable bottom paper which is disposed on a movable carrier.
- the upper surface of the aqueous mixture is then covered with a releasable top paper.
- the aqueous mixture, now effectively contained between releasable paper is advanced by the moveable carrier and sized to the desired thickness of the footbed.
- the footbed is then dried simultaneously with the removal of the releasable papers, or at any other advantageous time, to produce the foam footbed.
- the footbed is then cut to produce the desired size and shape of the final product.
- the footbed of the instant invention is then produced by an aqueous mixture of non-denatured collagen, water, prepolymer, and at least one additive.
- the additives of the instant invention are, in one embodiment, added to the aqueous mixture to a concentration of approximately 0.5% to approximately 15% by weight. Additive amounts less than approximately 0.5% by weight are unlikely to produce enough of a noticeable effect in the finished product, while additive amounts above approximately 15% by weight would likely produce a diminishing return in terms of functionality as more additive is included in the final composition.
- FIG. 4 shows one embodiment of the instant invention where at least one additive is dispersed 240 in the aqueous mixture.
- Said at least one additive includes skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
- the footbed also contains superabsorbent polymers.
- reaction composition components such as prepolymer and non-denatured collagen for including relatively high concentrations of functional additive will produce a more porous, less dense product which is advantageously used to provide for controlled release of said additive to the surroundings of the footbed.
- high concentrations of skin-care agents are combined with lower concentrations of prepolymer to provide a footbed which will release amounts of the skin-care agent to the wearer during use.
- FIG. 5 displays an additional embodiment in which an extra layer 500 is, added to the footbed 5 of the instant invention.
- the non-denatured collagen fibers 520 and the at least one additive 530 mentioned above are both uniformly dispersed throughout polymeric network 510 .
- the non-denatured collagen fibers 520 and the at least one additive 530 is selectively distributed throughout the polymeric network, such as being localized in the heel portion of the footbed or the ball portion of the footbed.
- This extra layer 500 is composed of any suitable material, said material being selected from, but not limited to, polymers or other fibers, which is applied to at least one part of the footbed.
- the extra layer in this additional embodiment is a cover layer for providing protection and additional mechanical strength to the composite material below.
- the cover layer allows for controlled material transport between the footbed and its surroundings.
- the cover layer acts as a moisture barrier or as a moisture wicking barrier, or allow for controlled release of an additive 530 from the footbed to its surroundings.
- the design of this functionality is well within the abilities of one of ordinary skill in the art.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a composition comprised of a prepolymer, at least one additive, and non-denatured collagen fibers and a method of making the same. The composition of the instant invention is for use as a footbed to augment the shock absorption already provided to the human body via a shoe and the collagenous, fatty pad of the human foot.
Description
- The invention relates to a composition comprising non-denatured collagen fibers complexed with a hydrophilic urethane foam and a method of making the same.
- The human foot is constructed to act as a natural shock absorber, cushioning the rest of the body from the forces encountered through movements such as walking, running, or jumping. With regards to shock absorption, the most vital structural component of the foot is the corpus adiposum of the heel, or heel pad. As a person ages, natural breakdown of the heel pad can lead to a loss of this natural shock absorption, potentially causing pain in either the foot or health problems in other parts of the body like the legs or lower back. Modern shoe technology has allowed manufacturers to counteract the loss of this natural shock adsorption by providing shoes with footbeds designed to act as auxiliary shock absorbers. Usually fashioned from a myriad of synthetic materials in the form of polymeric foams, these footbeds mimic the properties of the heel pad and help augment the natural shock absorption in the user's feet. Some footbeds have been produced with functional additives dispersed throughout the foam, endowing the footbed with functionalities such as moisture and odor absorption or skin care and treatment. However, these wholly synthetic footbeds can only approximate the healthy walking platform naturally provided by the human foot's heel pad. Further, fully synthetic footbeds are rarely made out of environmentally friendly materials, or at least made from recycled materials to limit excess waste in an increasingly environmentally conscious world.
- Complexes of polymers and collagenous matrices have been employed in the medical and surgical fields for their use as absorptive dressings or as synthetic replacements for naturally occurring human bodily tissues. The major hurdle in creating a polymer-collagen construct is the successful isolation of the collagen fibril. The fibers are often harvested using washes of harsh alkaline and acid solutions followed by drying in high heat and then mechanical disintegration. The result of all this treatment is a collagenous material with at least partial denaturation of vital structural linkages, leading to collection of fibers more akin to gelatin than cartilage. The resulting polymer-collagen constructs produced by through these harsh treatments are of a limited functionality, exhibiting lower melting points, lessened absorptive ability, and decreased structural rigidity than their naturally occurring analogues.
- What is desired, therefore, is a composition fashioned into a footbed for providing improved shock absorbing functionality to footwear. More particularly, what is desired is footbed with improved shock absorbing functionality which is fashioned utilizing environmentally conscious materials that does not sacrifice functionality, durability, or cost effective production and distribution. What is further desired is a composition and a method for providing a composition which harnesses the natural properties of non-denatured collagen fibers to fulfill the above-mentioned desires.
- It is therefore an object of the invention to provide a composition comprised of non-denatured collagen fibers and a polymeric network and a method of making the same to fashion footbeds with improved shock-absorption. In one embodiment, this is done through a method for providing a footbed with non-denatured collagen comprising the steps of forming an aqueous mixture having at least a predetermined amount of non-denatured collagen and water and metering a predetermined amount of a prepolymer with said aqueous mixture to form a foam layer. In another embodiment, the method further comprises the step of adding to the aqueous mixture an agent from the group consisting of: a cross-linking agent, a catalyst, and a combination thereof. In one embodiment of the instant invention, the method further comprises the steps of depositing the aqueous mixture on releasable bottom paper disposed on a movable carrier, covering the upper surface of the aqueous mixture with releasable top paper as the aqueous mixture is moved with the movable carrier, advancing the foam layer in the top and bottom release paper by moving the carrier, sizing the foam layer to the desired thickness, removing the top and bottom releasable paper and simultaneously drying the sized and formed footbed to remove moisture.
- In one embodiment, there is an additional step of dispersing the non-denatured collagen throughout the foam layer. In another embodiment, there is a step of dispersing at least one additive within the aqueous mixture. In an additional embodiment, the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
- One embodiment of the instant invention is a composite material for use as a footbed which comprises a prepolymer, a non-denatured collagen, and at least one additive. In another embodiment, the non-denatured collagen is dispersed throughout the composite material. In an additional embodiment, the non-denatured collagen is separated from a natural source and comprises non-denatured collagen fibrils, and an inter-fibril bond and an intra-fibril bond for retaining the structural rigidity of the non-denatured collagen are unbroken after separation. In one embodiment, a concentration of the at least one additive in the reaction composition is approximately 0.5% to approximately 15% by weight. In an additional embodiment, the non-denatured collagen has a denaturation temperature above 54 degrees Celsius. In yet another embodiment, the non-denatured collagen has a denaturation temperature above 64 degrees Celsius.
- In an additional embodiment, the non-denatured collagen is comprised of a cross-linked non-denatured collagen fiber in a configuration substantially similar to a naturally occurring collagen fiber. In another embodiment composite material is produced by a polymerization reaction composition further comprising a cross-linking agent for stabilizing a chemical and a physical interaction between the polymer and the non-denatured collagen. In one embodiment, a concentration of the prepolymer in the reaction composition is between approximately 10% and approximately 75% by weight. In a further embodiment, the composite material further includes a superabsorbent polymer. In an additional embodiment, the instant invention comprises at least one layer adjacent to the composite material.
- In one embodiment, the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof. In a further embodiment, the at least one layer is disposed as a cover layer.
- Finally, one embodiment of the instant invention is a reaction composition for use in producing a composite footbed comprising a urethane prepolymer, a non-denatured collagen fibril, an additive selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof, a cross-linking agent selected from the group consisting of: carbodiimides, acyl azides, glutaraldehyde, and combinations thereof, and a catalyst, wherein the composite footbed further comprises a layer disposed proximate to at least one portion of said footbed, and the layer is a cover layer.
- The features of the invention believed to be novel and the elements characteristic of the invention are set forth with particularity in the appended claims. The figures are for illustration purposes only and are not drawn to scale. The invention itself, however, both as to organization and method of operation, may be understood by reference to the detailed description which follows taken in conjunction with the accompanying drawings in which:
-
FIG. 1 depicts a molecular representation of a tropocollagen molecule. -
FIG. 2 a andFIG. 2 b depicts an embodiment of a construct of non-denatured collagen and a polymeric network as envisioned by the instant invention. -
FIG. 3 depicts a method of making a construct of non-denatured collagen and a polymeric network ofFIG. 2 a andFIG. 2 b. -
FIG. 4 depicts an embodiment of the method of adding at least one additive fromFIG. 3 . -
FIG. 5 depicts an embodiment of the instant invention in which the method described inFIG. 3 is used to provide a footbed and an additional cover layer. - In describing the various embodiments of the instant invention, reference will be made herein to
FIGS. 1-5 in which like numerals refer to like features of the invention. - A naturally occurring collagen fiber is stabilized by a plurality of forces, such as inter-fibril bonds and intra-fibril bonds. In the case of inter-fibril bonds, it is the bonding between collagen fibrils in a collagen fiber network that help increase the stability of the whole. The bonds can be covalent or non-covalent. The same can be said for intra-fibril bonds, however in this case it is the interactions within the individual tropocollagen that provide an internal stabilizing force.
FIG. 1 displays the tropocollagen molecule 10 of naturally occurring collagen fibrils. The intra-fibril bonds 1000 between the sub-units of this triple-helical structure provide for highly stable constructs which associate via inter-fibril (not-pictured) bonding with other like tropocollagen to form highly structured and stable networks of collagen fibers. The non-denatured collagen of this invention retain these inter and intra-fibril bonds, and therefore retain the stabilizing forces found in their naturally occurring counterparts. As a result, the non-denatured collagen of this invention maintain the advantageous properties from naturally occurring collagen absent in the denatured collagen of the prior art, namely increased stability at higher temperatures, improved absorption capabilities, and the like. - The separated non-denatured collagen of this invention retain the advantageous properties of naturally occurring collagen through a separation process which avoids the harsh acid, base, and temperature treatments so common in the prior art methods.
- Prior art methods typically utilize highly basic and highly acidic washes to facilitate separation of the naturally occurring collagen from a source, such as an animal hide. These washes, however, can have a profound effect on the fibrillar collagen structure, severing vital structural bonds and leading to lower denaturation temperatures of the separated collagen network. Prior art methods also commonly comprise a drying step, in which the separated collagen sample is subjected to high heat in order remove excess moisture from the sample. However, subjecting the separated collagen to high temperatures may cause at least partial denaturation of the collagen network, once again severing the vital structural bonds and leading to a more denatured collagen sample.
- By performing gentle acid and base washes and drying the separated collagen networks at lower temperatures, the separated collagen networks of this invention retain the structure and functionality of naturally occurring collagen networks, and therefore impart this functionality to consumer products better than the prior art collagen complexes. As a result, the separated non-denatured collagen fibers utilized in this invention closely mimic the behavior and functionality of naturally occurring collagen fibers. For instance, a common by-product of separated and processed collagen samples from the prior art is a lower denaturation temperature, often times as low as 50 degrees Celsius. However, in one embodiment, the non-denatured collagen of the instant invention have denaturation temperatures above 54 degrees Celsius, or in another embodiment greater than 64 degrees Celsius. The non-denatured collagen of the instant invention, therefore, retain more of the advantageous properties of naturally occurring collagen than do their prior art counterparts.
- The polymeric composition of the instant invention draws heavily on the teachings of U.S. Pat. No. 5,763,335, U.S. Pat. No. 5,976,616, U.S. Pat. No. 6,025,287, U.S. Pat. No. 6,566,576, and U.S. Pat. No. 6,706,775, all incorporated herein by reference. The prior art foam compositions and methods of making said foam compositions represent proven, powerful technology.
-
FIG. 5 shows one embodiment in which non-denatured collagen is complexed with a polymer to provide a footbed for a shoe. In this embodiment, the non-denatured collagen is shown to be distributed throughout the footbed, though in additional embodiments the non-denatured collagen is localized to certain regions of the footbed, such as only in the heel or only in the heel and the ball of the foot. The non-denatured collagen complexes with the polymer network of the footbed by any suitable means, such as chemical (covalent and non-covalent bonding) or physical interactions. Non-denatured collagen fibrils are known to have active sites and pendant groups available for reaction. In one embodiment, the non-denatured collagen is of the Type-II variety, though the invention is not limited to the use of Type-II collagen alone. Type-II collagen allows for a certain degree of reversible compressibility, making it ideal for use in the footbed of the instant invention. -
FIG. 3 shows one embodiment of the method of making a footbed with non-denatured collagen. After separation of a non-denatured collagen sample from, in one embodiment, a natural source such as a bovine hide, an aqueous mixture is formed 100 having a mixture of said non-denatured collagen and water. In one embodiment, the amount of water in the aqueous mixture is between approximately 15% and approximately 95% by weight. Less than approximately 15% water by weight will lead to unnecessary difficulties during the component admixing process, while concentrations of approximately 95% by weight will disadvantageously limit the amounts other components are added to the composition. To this aqueous mixture is metered 110 a predetermined amount of a prepolymer, such as those taught in U.S. Pat. No. 5,763,335, incorporated herein by reference, to form a foam layer for the footbed. In one embodiment, the predetermined amount of prepolymer is approximately 10% to approximately 75% by weight of the aqueous mixture, which covers the approximate operational range of the present invention. Below approximately 10% by weight prepolymer in the aqueous mixture yields a final composition with compromised durability and stability characteristics, whereas above approximately 75% by weight of the aqueous mixture unduly limits the available space for other components without necessarily imparting any further advantageous functionality to the finished product to compensate. In some embodiments, the range is closer to approximately 20% to approximately 50% by weight of the aqueous mixture, said range striking an advantageous balance between durability, cost-effectiveness, and sufficient space for other components. In an exemplary embodiment, the prepolymer is a urethane and part of a two-part urethane system. In one embodiment, as mentioned above, the non-denatured collagen is dispersed 120 throughout the whole footbed, or be localized to a specific region of the footbed. Also, in one embodiment, at least one additive is present in the aqueous mixture. The complexing of the polymers and the non-denatured collagen is aided by theaddition 130 of a cross-linking agent to the aqueous mixture. Cross-linking agents increase the total number of interactions between the various components of the footbed, whether they be collagen-collagen, collagen-prepolymer, prepolymer-prepolymer interactions, or the like. The advantage of additional interactions is increased mechanical strength and denaturation resistance. Cross-linking agents suitable for use in the reaction composition of the instant invention include, but are not limited to, carbodiimides, acyl azides, glutaraldehyde, and the like. In another embodiment, a catalytic agent is added to the aqueous mixture to promote the polymerization reaction between the non-denatured collagen fibrils and the prepolymer. Potentially useful catalysts include, but are not limited to, methylene blue, riboflavin, proflavin, eosin, pyridoxal-5-phosphate, and the like. - Ultimately, the non-denatured collagen/polymer complex 2 of the instant invention resembles the structure portrayed in
FIG. 2 a andFIG. 2 b. Thenon-denatured collagen 210 is stabilized internally through the aforementioned inter- and intra-fibril bonds, and is then complexed with the polymeric network 200 through chemical or physical interactions, and then stabilized by crosslinking. - Again with reference to
FIG. 1 , in some embodiments, the aqueous mixture is deposited 140 on releasable bottom paper which is disposed on a movable carrier. The upper surface of the aqueous mixture is then covered with a releasable top paper. The aqueous mixture, now effectively contained between releasable paper, is advanced by the moveable carrier and sized to the desired thickness of the footbed. In one embodiment, the footbed is then dried simultaneously with the removal of the releasable papers, or at any other advantageous time, to produce the foam footbed. The footbed is then cut to produce the desired size and shape of the final product. - As mentioned above, the footbed of the instant invention is then produced by an aqueous mixture of non-denatured collagen, water, prepolymer, and at least one additive. The additives of the instant invention are, in one embodiment, added to the aqueous mixture to a concentration of approximately 0.5% to approximately 15% by weight. Additive amounts less than approximately 0.5% by weight are unlikely to produce enough of a noticeable effect in the finished product, while additive amounts above approximately 15% by weight would likely produce a diminishing return in terms of functionality as more additive is included in the final composition.
FIG. 4 shows one embodiment of the instant invention where at least one additive is dispersed 240 in the aqueous mixture. Said at least one additive includes skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof. In an additional embodiment, the footbed also contains superabsorbent polymers. The above list of additives should not be considered limiting, as selecting any other similar additive deemed useful in performing the instant invention is well within the ability of one of ordinary skill in the art. - Admixing the aqueous mixture comprising non-denatured collagen and water with the prepolymer as described above initiates a polymerization reaction. Complexing of the prepolymer and non-denatured collagen sample is facilitated through the aforementioned active sites and pendant groups on the non-denatured collagen fibrils. The physical characteristics of the final footbed product are controlled through adjustments to the reaction composition. For instance, increases in the weight % of prepolymer and non-denatured collagen in the reaction composition will produce a more resilient, dense material suitable perhaps for use under more rigorous conditions, such as hiking, sporting pursuits, and the like. However, scaling back the weight % of reaction composition components such as prepolymer and non-denatured collagen for including relatively high concentrations of functional additive will produce a more porous, less dense product which is advantageously used to provide for controlled release of said additive to the surroundings of the footbed. In one embodiment, high concentrations of skin-care agents are combined with lower concentrations of prepolymer to provide a footbed which will release amounts of the skin-care agent to the wearer during use.
-
FIG. 5 displays an additional embodiment in which anextra layer 500 is, added to the footbed 5 of the instant invention. In one embodiment, and as evidenced inFIG. 5 , the non-denatured collagen fibers 520 and the at least one additive 530 mentioned above are both uniformly dispersed throughout polymeric network 510. As previously described, in other embodiments the non-denatured collagen fibers 520 and the at least oneadditive 530 is selectively distributed throughout the polymeric network, such as being localized in the heel portion of the footbed or the ball portion of the footbed. Thisextra layer 500 is composed of any suitable material, said material being selected from, but not limited to, polymers or other fibers, which is applied to at least one part of the footbed. The extra layer in this additional embodiment is a cover layer for providing protection and additional mechanical strength to the composite material below. In yet another embodiment, the cover layer allows for controlled material transport between the footbed and its surroundings. For example, the cover layer acts as a moisture barrier or as a moisture wicking barrier, or allow for controlled release of an additive 530 from the footbed to its surroundings. The design of this functionality is well within the abilities of one of ordinary skill in the art. - While the present invention has been particularly described, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art in light of the foregoing description. It is therefore contemplated that the appended claims will embrace any such alternatives, modifications, and variations as falling within the true scope and spirit of the present invention.
Claims (20)
1. A method for providing a footbed with non-denatured collagen comprising the steps of:
forming an aqueous mixture having at least a predetermined amount of non-denatured collagen and water;
metering a predetermined amount of a prepolymer with said aqueous mixture to form a foam layer.
2. The method of claim 1 , further comprising the step of adding to the aqueous mixture an agent from the group consisting of: a cross-linking agent, a catalyst, and a combination thereof.
3. The method of claim 2 , further comprising the following steps:
depositing the aqueous mixture on releasable bottom paper disposed on a movable carrier;
covering the upper surface of the aqueous mixture with releasable top paper as the aqueous mixture is moved with the movable carrier;
advancing the foam layer in the top and bottom release paper by moving the carrier;
sizing the foam layer to the desired thickness;
removing the top and bottom releasable paper and simultaneously drying the sized and formed footbed to remove moisture.
4. The method of claim 1 , dispersing the non-denatured collagen throughout the foam layer.
5. The method of claims 1 , dispersing at least one additive within the aqueous mixture.
6. The method of claim 5 , wherein the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents; surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
7. A composite material for use as a footbed comprising a prepolymer, a non-denatured collagen, and at least one additive.
8. The composite material of claim 7 , wherein the non-denatured collagen is dispersed throughout the composite material.
9. The composite material of claim 7 , wherein the non-denatured collagen is separated from a natural source and comprises non-denatured collagen fibrils, and wherein an inter-fibril bond and an intra-fibril bond for retaining the structural rigidity of the non-denatured collagen are unbroken after separation.
10. The composite material of claim 7 , wherein a concentration of the at least one additive in the reaction composition is approximately 0.5% to approximately 15% by weight.
11. The composite material of claim 7 , wherein the non-denatured collagen has a denaturation temperature above 54 degrees Celsius.
12. The composite material of claim 11 , wherein the non-denatured collagen has a denaturation temperature above 64 degrees Celsius.
13. The composite material of claim 7 , wherein the non-denatured collagen is comprised of a cross-linked non-denatured collagen fiber in a configuration substantially similar to a naturally occurring collagen fiber.
14. The composite material of claim 7 , wherein the composite material is produced by a polymerization reaction composition further comprising a cross-linking agent for stabilizing a chemical and a physical interaction between the polymer and the non-denatured collagen.
15. The composite material of claim 7 , wherein a concentration of the prepolymer in the reaction composition is between approximately 10% and approximately 75% by weight.
16. The composite material of claim 15 , wherein the composite material further includes a superabsorbent polymer.
17. The composite material of claim 7 , further comprising at least one layer adjacent to the composite material.
18. The composite material of claim 7 , wherein the at least one additive is selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof.
19. The composite of claim 17 , wherein the at least one layer is disposed as a cover layer.
20. A reaction composition for use in producing a composite footbed comprising the following:
a urethane prepolymer;
a non-denatured collagen fibril;
an additive selected from the group consisting of: skin care agents, hydrocolloid absorptive agents, medicaments, proteins, enzymes, nucleic acids, vitamins, soaps, hemostatic agents, antibacterial agents, antifungal agents, surfactants, pH buffers, rubber particles, disinfecting and sterilizing agents, thermal phase change particles, and combinations thereof;
a cross-linking agent selected from the group consisting of:
carbodiimides, acyl azides, glutaraldehyde, and combinations thereof;
and a catalyst;
wherein the composite footbed further comprises a layer disposed proximate to at least one portion of said footbed, and the layer is a cover layer.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/176,841 US20130011451A1 (en) | 2011-07-06 | 2011-07-06 | Footbed with non-denatured collagen |
US13/633,605 US9403953B2 (en) | 2011-07-06 | 2012-10-02 | Cosmetic sponge and method for providing a cosmetic sponge |
US15/189,184 US10259914B2 (en) | 2011-07-06 | 2016-06-22 | Cosmetic sponge and method for providing a cosmetic sponge |
US16/289,780 US11124611B2 (en) | 2011-07-06 | 2019-03-01 | Cosmetic sponge and method for providing a cosmetic sponge |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/176,841 US20130011451A1 (en) | 2011-07-06 | 2011-07-06 | Footbed with non-denatured collagen |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/633,605 Continuation US9403953B2 (en) | 2011-07-06 | 2012-10-02 | Cosmetic sponge and method for providing a cosmetic sponge |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130011451A1 true US20130011451A1 (en) | 2013-01-10 |
Family
ID=47438793
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/176,841 Abandoned US20130011451A1 (en) | 2011-07-06 | 2011-07-06 | Footbed with non-denatured collagen |
US13/633,605 Expired - Fee Related US9403953B2 (en) | 2011-07-06 | 2012-10-02 | Cosmetic sponge and method for providing a cosmetic sponge |
US15/189,184 Expired - Fee Related US10259914B2 (en) | 2011-07-06 | 2016-06-22 | Cosmetic sponge and method for providing a cosmetic sponge |
US16/289,780 Active 2031-08-27 US11124611B2 (en) | 2011-07-06 | 2019-03-01 | Cosmetic sponge and method for providing a cosmetic sponge |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/633,605 Expired - Fee Related US9403953B2 (en) | 2011-07-06 | 2012-10-02 | Cosmetic sponge and method for providing a cosmetic sponge |
US15/189,184 Expired - Fee Related US10259914B2 (en) | 2011-07-06 | 2016-06-22 | Cosmetic sponge and method for providing a cosmetic sponge |
US16/289,780 Active 2031-08-27 US11124611B2 (en) | 2011-07-06 | 2019-03-01 | Cosmetic sponge and method for providing a cosmetic sponge |
Country Status (1)
Country | Link |
---|---|
US (4) | US20130011451A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107483649A (en) * | 2017-10-12 | 2017-12-15 | 福建富士通信息软件有限公司 | A kind of cross-platform log collection method based on Kaa services |
US20180375710A1 (en) * | 2015-12-21 | 2018-12-27 | Lg Electronics Inc. | Method and apparatus for generating and transmitting reference signal and data in wireless communication system |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2842501T5 (en) | 2015-09-21 | 2023-04-13 | Modern Meadow Inc | Fiber Reinforced Fabric Composite Materials |
US9897378B2 (en) | 2015-10-08 | 2018-02-20 | Nyc Designed Inspirations Llc | Cosmetic makeup sponge/blender container |
KR20180101551A (en) * | 2016-01-19 | 2018-09-12 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Consumer scrubbing article having stain release property and manufacturing method thereof |
CN107530474A (en) | 2016-02-15 | 2018-01-02 | 现代牧场股份有限公司 | Method for the biological production of composite materials |
USD822904S1 (en) * | 2016-02-24 | 2018-07-10 | Nyc Designed Inspirations Llc | Cosmetic makeup sponge/blender container |
KR101849205B1 (en) | 2016-11-08 | 2018-04-16 | 박영미 | Beauty brush production method using the latex |
AU2018253595A1 (en) | 2017-11-13 | 2019-05-30 | Modern Meadow, Inc. | Biofabricated leather articles having zonal properties |
CN108434021B (en) * | 2018-06-04 | 2020-03-31 | 内蒙古骆驼研究院 | Hump fat hand cream with skin moistening and anti-cracking effects and preparation method thereof |
USD874126S1 (en) * | 2018-06-21 | 2020-02-04 | Orchard International Inc. | Sponge case |
CN113286864A (en) * | 2019-01-17 | 2021-08-20 | 现代牧场股份有限公司 | Layered collagen material and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976616A (en) * | 1998-10-02 | 1999-11-02 | H.H. Brown Shoe Technologies, Inc. | Polyurethane foam materials with skin conditioning additives |
US20030078532A1 (en) * | 2000-03-03 | 2003-04-24 | Zbigniew Ruszczak | Composite dressings for the treatment of wounds |
US6566576B1 (en) * | 2000-01-04 | 2003-05-20 | James F. Komerska | Hydrocolloid foam medical dressings and method of making the same |
US20030191204A1 (en) * | 2002-04-02 | 2003-10-09 | H.H. Brown Shoe Technologies, Inc. D/B/A Dicon Technologies | Polyurethane foam products with controlled release of agents and additives |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3471598A (en) | 1966-02-14 | 1969-10-07 | Fmc Corp | Method of producing absorbent mats |
US3632361A (en) | 1969-06-26 | 1972-01-04 | Fmc Corp | Water-insoluble microcrystalline collagen absorbent mat |
US3665988A (en) | 1970-03-31 | 1972-05-30 | Us Agriculture | Process for producing granular and fibrous collagen dispersions |
US3800792A (en) | 1972-04-17 | 1974-04-02 | Johnson & Johnson | Laminated collagen film dressing |
US3949137A (en) | 1974-09-20 | 1976-04-06 | Akrongold Harold S | Gel-impregnated sponge |
DE2517452C3 (en) | 1975-04-19 | 1978-11-02 | Fa. Carl Freudenberg, 6940 Weinheim | Collagen foil for cosmetic use |
DE3065372D1 (en) * | 1979-09-07 | 1983-11-24 | Kingsdown Medical Consultants | Wound dressing |
US4412947A (en) | 1979-09-12 | 1983-11-01 | Seton Company | Collagen sponge |
US4327195A (en) | 1980-09-29 | 1982-04-27 | Seton Company | Polyurethane containing polypeptides |
US4914170A (en) | 1987-11-17 | 1990-04-03 | Rohm And Haas Company | Superabsorbent polymeric compositions and process for producing the same |
US5207705A (en) | 1988-12-08 | 1993-05-04 | Brigham And Women's Hospital | Prosthesis of foam polyurethane and collagen and uses thereof |
US5106949A (en) | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
JPH03260178A (en) | 1990-03-06 | 1991-11-20 | Showa Shell Sekiyu Kk | Production of water-absorbing and water-retaining flexible cloth |
US5523291A (en) | 1993-09-07 | 1996-06-04 | Datascope Investment Corp. | Injectable compositions for soft tissue augmentation |
ES2229277T3 (en) | 1995-06-07 | 2005-04-16 | Organogenesis Inc. | COMPOSITIONS OF FIBER SEGMENTS OF COLOGEN RECONSTITUTED AND METHODS FOR THEIR PREPARATION. |
US5763335A (en) | 1996-05-21 | 1998-06-09 | H.H. Brown Shoe Technologies, Inc. | Composite material for absorbing and dissipating body fluids and moisture |
US20020099318A1 (en) * | 1997-05-16 | 2002-07-25 | Susan Suehr | Multi-layer compression bandage |
GB2345638A (en) | 1998-09-11 | 2000-07-19 | Tissue Science Lab Limited | Injectable collagen compositions |
JP3010160B1 (en) | 1998-10-28 | 2000-02-14 | 株式会社ニッピ | Collagen-containing cosmetics |
IT1317832B1 (en) * | 2000-02-15 | 2003-07-15 | Eurores S R L | PROCEDURE FOR THE PREPARATION OF MICRONIZED COLLAGEN AND THERAPEUTIC APPLICATIONS. |
BR0203122A (en) | 2002-07-19 | 2003-04-08 | Novaprom Food Ingredients Ltda | Process for obtaining undenatured fiber collagen |
BRPI0902991A2 (en) | 2009-08-24 | 2010-06-29 | Novaprom Food Ingredients Ltda | process for the extraction of collagen protein from bovine skin |
-
2011
- 2011-07-06 US US13/176,841 patent/US20130011451A1/en not_active Abandoned
-
2012
- 2012-10-02 US US13/633,605 patent/US9403953B2/en not_active Expired - Fee Related
-
2016
- 2016-06-22 US US15/189,184 patent/US10259914B2/en not_active Expired - Fee Related
-
2019
- 2019-03-01 US US16/289,780 patent/US11124611B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976616A (en) * | 1998-10-02 | 1999-11-02 | H.H. Brown Shoe Technologies, Inc. | Polyurethane foam materials with skin conditioning additives |
US6566576B1 (en) * | 2000-01-04 | 2003-05-20 | James F. Komerska | Hydrocolloid foam medical dressings and method of making the same |
US20030078532A1 (en) * | 2000-03-03 | 2003-04-24 | Zbigniew Ruszczak | Composite dressings for the treatment of wounds |
US20030191204A1 (en) * | 2002-04-02 | 2003-10-09 | H.H. Brown Shoe Technologies, Inc. D/B/A Dicon Technologies | Polyurethane foam products with controlled release of agents and additives |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180375710A1 (en) * | 2015-12-21 | 2018-12-27 | Lg Electronics Inc. | Method and apparatus for generating and transmitting reference signal and data in wireless communication system |
CN107483649A (en) * | 2017-10-12 | 2017-12-15 | 福建富士通信息软件有限公司 | A kind of cross-platform log collection method based on Kaa services |
Also Published As
Publication number | Publication date |
---|---|
US20190194398A1 (en) | 2019-06-27 |
US9403953B2 (en) | 2016-08-02 |
US11124611B2 (en) | 2021-09-21 |
US20130028949A1 (en) | 2013-01-31 |
US20180237592A1 (en) | 2018-08-23 |
US10259914B2 (en) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20130011451A1 (en) | Footbed with non-denatured collagen | |
Lu et al. | Insoluble and flexible silk films containing glycerol | |
ES2805023T3 (en) | Composite material biofabrication procedure | |
US11214844B2 (en) | Biofabricated leather articles having zonal properties | |
Silva et al. | Protein-based materials: from sources to innovative sustainable materials for biomedical applications | |
AU2011296133B2 (en) | A high strength chitin composite material and method of making | |
WO2019017987A1 (en) | Biofabricated leather articles, and methods thereof | |
Saha et al. | Keratin as a Biopolymer | |
Ossai et al. | Valorisation of keratinous wastes: A sustainable approach towards a circular economy | |
Sharma et al. | Keratin: an introduction | |
Ramesh et al. | Keratin-based biofibers and their composites | |
CN109206699A (en) | A kind of latex product and preparation method thereof | |
KR101269979B1 (en) | The shoes inserts for erasing bad smelling | |
JP5544588B2 (en) | Peptide bond compatible polyurethane resin composition and molded product thereof | |
KR20020090938A (en) | High performance airing insole made of textile waste and process therefor | |
Fassini et al. | Biotechnological valorization of marine collagens: biomaterials for health applications | |
CN106009089A (en) | Sponge rubber insole material with fruitwood delicate fragrance and preparation method thereof | |
Kalia et al. | Protein-Based Biopolymers: From Source to Biomedical Applications | |
Wongpanit et al. | Silk fibre composites | |
CN118716729A (en) | Men's shoes with antidetonation deodorant function | |
Dutta et al. | Silk Biomaterials is an Essential Tool and Potential Applications in Biomedical Industries-A Review | |
Costa et al. | proteins) for tissue regeneration and repair | |
Ahmad | Abattoir waste valorization: potential utilization of by-products into value-added chains | |
Brown | Minimally Invasive Silk Biomaterials for Soft Tissue Augmentation | |
CN110881745A (en) | Preparation method of shock-absorbing deodorant insole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DIVERSIFIED GLOBAL TECHNOLOGIES, LLC, RHODE ISLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CELIA, WAYNE;REEL/FRAME:026550/0446 Effective date: 20110705 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |